Hear what Ipsen CEO David Loew has to say about our strong full year and Q4 2022 results.
Tag: Corporate
Ipsen anti-corruption system certification renewed in 2022
In December 2021, Ipsen received ISO 37001 certification for its anti-corruption management systems by Eurocompliance, a certification organization dedicated to
A word from CEO David Loew
“Our growth platforms have delivered strong sales performance, reflecting improving commercial execution and the strength for our portfolio.” CEO David
Ipsen becomes a founding sponsor of the second Biolabs innovation hub in Europe at Hopital Hotel Dieu, AP-HP
Ipsen announces that it becomes a founding sponsor of the second Biolabs innovation brain hub in Europe at Hopital Hotel
Ipsen receives SBTi approval for climate targets
In October 2021, Ipsen pledged ambitious action on climate change. Today, we announce that Ipsen’s Climate Targets were approved by
Epizyme welcome to Ipsen
Hear what CEO David Loew has to say about the official close of its acquisition of Epizyme.
A message from CEO David Loew
Hear what CEO David Loew has to say about our H1 2022 results.
Ukraine situation: What Ipsen is doing
Latest Update: March 29, 2022 The on-going tragedy in Ukraine is profoundly worrying, and our thoughts are with everyone impacted.
Ipsen has been certified by Eurocompliance to the ISO 37001 standards for anti-corruption management systems.
On the 15th of December 2021, Ipsen has been certified by Eurocompliance to the ISO 37001 standards for anti-corruption management
Ipsen continues to strengthen early oncology pipeline with Queen’s University Belfast collaboration and licensing agreement.
Today we are pleased to announce a partnership with the Queen’s University of Belfast (QUB), securing rights to a preclinical